The Neurovascular Devices/Interventional Neurology Market is expected to reach USD 4,240 million by 2026, growing at a CAGR of 9.1%, over the forecast period till--2026

The factors driving growth of the Neurovascular Devices/Interventional Neurology Market includes Increasing prevalence of neurovascular disorders around the world, expansion of the pharmaceutical industry, growing demand for minimally invasive surgeries, rise in the geriatric population and improvements in the living standards. According to the report published by National Library of Medicines (NLM), the prevalence of neuromuscular conditions across United Kingdom has risen by 63% since 2000 and is increasingly seen in population aged 65 and above, which is expected to push the demand for neurovascular devices in the approaching years. Moreover, technological advancements in neurovascular devices, increase in government’s expenditure on the healthcare sector, rise in the launch of innovative products, growing focus on manufactures on expanding production capacity and rapid urbanization, are some of the additional factors supplementing the market growth. In addition, the increasing investments by leading players on research and development, strategic partnerships and collaborations between enterprises and growing disposable incomes, are further propelling the Neurovascular Devices/Interventional Neurology Market size.

However, growth of the Neurovascular Devices/Interventional Neurology Market is hindered due to high procedural costs.

The major players operating in the market includes Johnson & Johnson, Terumo Corporation, Penumbra Inc., Boston Scientific Corporation, Abbott Laboratories, W.L. Gore & Associates Inc., Stryker Corporation, Medtronic PLC, Microport Scientific Corporation, and Merit Medical Systems Inc., among others.

Based on Product, the Aneurysm Coiling & Embolization Devices segment is predicted to dominate the market during the forecast period

Increasing use of aneurism coiling and embolization devices in minimally invasive neurosurgical procedures, is pushing segment’s growth.

Based on Disease pathology, the Cerebral Aneurysms segment is projected to hold the highest market share over the forecast period

Increase in healthcare expenditure in developing countries and rising prevalence of diabetes and obesities, are propelling segment’s growth. 

Based on Region, the North American region is expected to lead the market during the forecast period

As per the Neurovascular Devices Market Research Report, presence of the leading players such as Johnson & Johnson, Boston Scientific Corporation, and Abbott Laboratories, increasing prevalence of neurovascular diseases, rising geriatric population and high per capita incomes, are some of the important factors augmenting the market growth in North America.

Market Segmentation

Segmentation By Product

  • Aneurysm Coiling & Embolization Devices
    • Cerebral Balloon Angioplasty and Stenting Systems
    • Support Devices
    • Neurothrombectomy Devices

Segmentation By Disease Pathology

  • Ischemic Strokes
    • Cerebral Aneurysms
    • Arteriovenous Malformation and Fistulas
    • Other Disease Pathologies

Segmentation By End User

  • Hospitals
    • Clinics
    • Ambulatory Surgical Centers

Segmentation by Region

  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of APAC
  • North America
    • United States of America
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Spain
    • Rest of Europe
  • RoW
    • Brazil
    • South Africa
    • Saudi Arabia
    • UAE

About GMI Research

GMI Research is a market research and consulting firm which provides market insights and intelligence across 12 major sectors helping our clients in making effective investment and business decisions.

Media Contact
Company Name: GMI RESEARCH
Contact Person: Sarah Nash
Email: [email protected]
Phone: Europe – +353 1 442 8820; US – +1 860 881 2270
Address: Dublin, Ireland
Website: https://www.gmiresearch.com